| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.28▼ | 6.27▼ | 6.27▼ | 6.33▼ | 6.48▼ |
| MA10 | 6.27▼ | 6.29▼ | 6.31▼ | 6.30▼ | 6.44▼ |
| MA20 | 6.29▼ | 6.28▼ | 6.26▼ | 6.41▼ | 6.02▲ |
| MA50 | 6.26▼ | 6.29▼ | 6.28▼ | 6.40▼ | 4.84▲ |
| MA100 | 6.27▼ | 6.47▼ | 6.50▼ | 5.92▲ | 4.17▲ |
| MA200 | 6.58▼ | 6.42▼ | 6.36▼ | 5.07▲ | 4.31▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.005▼ | 0.002▲ | -0.017▼ | -0.063▼ |
| RSI | 46.337▼ | 46.634▼ | 47.093▼ | 46.790▼ | 55.591▲ |
| STOCH | 55.556 | 23.283 | 31.481 | 58.044 | 53.509 |
| WILL %R | -83.333▼ | -88.235▼ | -55.556 | -61.538 | -62.703 |
| CCI | -73.510 | -71.709 | -33.828 | -36.364 | -21.478 |
|
Wednesday, August 14, 2019 05:00 PM
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is ...
|
|
Thursday, August 01, 2019 04:20 AM
iCAD (NASDAQ:ICAD): Q2 GAAP EPS of -$0.20 misses by $0.10. Revenue of $7.33M (+19.0% Y/Y) beats by $0.51M.
|
|
Saturday, July 20, 2019 02:15 AM
July 11, 2019 08:00 ET | Source: iCAD, Inc. NASHUA, N.H., July 11, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/08/19 | 6.24 | 6.25 | 6.24 | 6.25 | 40,156 |
| 21/08/19 | 6.33 | 6.38 | 6.16 | 6.37 | 48,600 |
| 20/08/19 | 6.414 | 6.42 | 6.22 | 6.29 | 16,263 |
| 19/08/19 | 6.40 | 6.48 | 6.30 | 6.40 | 21,500 |
| 16/08/19 | 6.30 | 6.38 | 6.15 | 6.32 | 34,900 |
| 15/08/19 | 6.27 | 6.43 | 6.09 | 6.25 | 135,200 |
| 14/08/19 | 6.15 | 6.40 | 6.01 | 6.30 | 175,200 |
| 13/08/19 | 6.14 | 6.52 | 6.14 | 6.35 | 66,302 |
| 12/08/19 | 6.25 | 6.40 | 6.12 | 6.19 | 61,000 |
| 09/08/19 | 6.30 | 6.38 | 6.05 | 6.28 | 83,100 |
|
|
||||
|
|
||||
|
|